scholarly article | Q13442814 |
P2093 | author name string | Stangel M | |
Boegner F | |||
Klatt CH | |||
Seyfert S | |||
Hofmeister C | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | placebo | Q269829 |
P304 | page(s) | 89-92 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis | |
P478 | volume | 68 |
Q47835493 | Achievements and obstacles of remyelinating therapies in multiple sclerosis. |
Q36602762 | Basic principles of intravenous immunoglobulin (IVIg) treatment |
Q35172531 | Cell transplantation, myelin repair, and multiple sclerosis |
Q36963208 | Emerging therapies for multiple sclerosis |
Q35981192 | Escalating immunotherapy of multiple sclerosis--new aspects and practical application. |
Q37989903 | FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination |
Q51777739 | IVIG trials in MS. Is albumin a placebo? |
Q50751771 | Interferon Beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in Iran. |
Q36602782 | Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis |
Q37030423 | Intravenous polyclonal human immunoglobulins in multiple sclerosis |
Q37419064 | Neuroprotection and neuroregeneration in multiple sclerosis |
Q41173378 | New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins |
Q73384061 | Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination |
Q73276229 | Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors |
Q35046922 | Remyelinating strategies for the treatment of multiple sclerosis |
Q36113038 | Stem cell therapy for central nervous system demyelinating disease |
Q35057210 | The role of intravenous immunoglobulin in the treatment of multiple sclerosis |
Q80953233 | [Immunomodulatory effects of intravenous immunoglobulins] |
Q80257893 | [Use of i.v. immunoglobulins in neurology. Evidence-based consensus] |
Search more.